| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/05/2007 | US20070154543 Solid preparation for oral use |
| 07/05/2007 | US20070154542 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 07/05/2007 | US20070154541 Seamless capsule containing water-soluble active substance |
| 07/05/2007 | US20070154540 Composition for treatment of osteoarthritis containing apigenin as chondroregenerative agent |
| 07/05/2007 | US20070154539 Nanolipidic particles |
| 07/05/2007 | US20070154538 Removal of fat cells by PDT |
| 07/05/2007 | US20070154537 Lipid-derivatized bisphosphonic acid |
| 07/05/2007 | US20070154536 Drug delivery method by enhanced topical application |
| 07/05/2007 | US20070154535 Tulobuterol adhesive patch |
| 07/05/2007 | US20070154534 Use of secretin in the treatment of schizophrenia |
| 07/05/2007 | US20070154531 Anti-inflammatory analgesic preparation |
| 07/05/2007 | US20070154528 Flexible wound dressing |
| 07/05/2007 | US20070154527 Topical film compositions for delivery of actives |
| 07/05/2007 | US20070154512 Low temperature drying methods for forming drug-containing polymeric compositions |
| 07/05/2007 | US20070154497 Stable, palatable syrup containing ibuprofen and method of its preparation |
| 07/05/2007 | US20070154495 Modified whole cell, cell extract and omv-based vaccines |
| 07/05/2007 | US20070154494 Anthrax vaccines and delivery methods |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154457 Use of eIF-5A to kill multiple myeloma cells |
| 07/05/2007 | US20070154449 Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compounds |
| 07/05/2007 | US20070154448 Methods and compositions using Substance P to promote wound healing |
| 07/05/2007 | US20070154408 Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof |
| 07/05/2007 | US20070154407 Inhaler and store for a dry medicament formulation and related methods and use thereof |
| 07/05/2007 | US20070154406 Spray-dried collectin compositions and process for preparing the same |
| 07/05/2007 | US20070154405 aerosol apparatus containing a composition for applying simultaneously several topical stimuli |
| 07/05/2007 | US20070154404 Insulin highly respirable microparticles |
| 07/05/2007 | US20070154403 Oral, Pulmonary and Transmucosal Delivery Composition |
| 07/05/2007 | US20070154402 Topical Pharmaceutical Foam Composition |
| 07/05/2007 | US20070154401 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154400 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070152360 Microparticles, microparticle production method, and microparticle production apparatus |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | DE102005062440A1 Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen Protein-based carrier system to overcome resistance of tumor cells |
| 07/05/2007 | DE102005061278A1 Sonnenbrandtuch Sunburn cloth |
| 07/05/2007 | CA2826746A1 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide |
| 07/05/2007 | CA2798511A1 Gastric reflux resistant dosage forms |
| 07/05/2007 | CA2635575A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 07/05/2007 | CA2635518A1 Agent for prophylactic and/or therapeutic treatment of chronic obstructive pulmonary disease |
| 07/05/2007 | CA2635038A1 Method for modifying gut flora in animals |
| 07/05/2007 | CA2635013A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 07/05/2007 | CA2634969A1 Controlled release solid preparation |
| 07/05/2007 | CA2634830A1 Degradable polymeric microsphere composition |
| 07/05/2007 | CA2634734A1 Iontophoretic transdermal delivery of nicotine salts |
| 07/05/2007 | CA2634637A1 Controlled release solid preparation |
| 07/05/2007 | CA2634481A1 Masking the taste of powders |
| 07/05/2007 | CA2634479A1 Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same |
| 07/05/2007 | CA2634232A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | CA2634094A1 Pharmaceutical formulations of fenofibrate having improved bioavailability |
| 07/05/2007 | CA2633825A1 Lansoprazole orally disintegrating tablets |
| 07/05/2007 | CA2633684A1 Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
| 07/05/2007 | CA2633655A1 Topical mecamylamine formulations for ocular administration and uses therof |
| 07/05/2007 | CA2633638A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof |
| 07/05/2007 | CA2633608A1 Long term weight maintenance |
| 07/05/2007 | CA2633380A1 Nanoclusters for delivery of therapeutics |
| 07/05/2007 | CA2633369A1 Transdermal delivery of meptazinol |
| 07/05/2007 | CA2633356A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | CA2633353A1 Stable s-nitrosothiol formulations |
| 07/05/2007 | CA2633254A1 Pharmaceutical compositions of ilaprazole |
| 07/05/2007 | CA2633238A1 Compositions and methods for oxalate reduction |
| 07/05/2007 | CA2632213A1 Oral formulations comprising tigecycline |
| 07/05/2007 | CA2631431A1 Ph modulated films for delivery of actives |
| 07/05/2007 | CA2631003A1 Protein-based delivery system for overcoming resistance in tumour cells |
| 07/04/2007 | EP1803469A2 Medicaments for inhalation comprising betamimetics and an anticholinergic |
| 07/04/2007 | EP1803462A2 Application of compounds containing petasites for treating diseased states |
| 07/04/2007 | EP1803460A1 Composition and method for therapy or prevention of mental symptom |
| 07/04/2007 | EP1803450A1 Pharmaceutical compositions for the eradication of helicobacter pylori |
| 07/04/2007 | EP1803449A2 Modified release formulation of lithium carbonate and method for the preparation thereof |
| 07/04/2007 | EP1803448A2 Tasted masked veterinary solid compositions |
| 07/04/2007 | EP1803447A1 Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment |
| 07/04/2007 | EP1803446A1 Orally disintegrating tablet and method of preparation |
| 07/04/2007 | EP1803445A2 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/04/2007 | EP1803444A2 A method for the preparation of a nicotine-containing particulate material with a crystalline cellulose (in particular MCC) |
| 07/04/2007 | EP1803443A2 A method for the preparation of a nicotine-containing particulate material with a crystalline cellulose (in particular MCC) |
| 07/04/2007 | EP1803442A1 Mineralized hydrogels and methods of making and using mineralized hydrogels |
| 07/04/2007 | EP1803441A1 Pharmaceutical formulations of fenofibrate having improved bioavailability |
| 07/04/2007 | EP1803440A1 Pharmaceutical formulation comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 07/04/2007 | EP1802746A2 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 07/04/2007 | EP1802357A2 Contact lens package solution |
| 07/04/2007 | EP1802347A1 Anti-snoring composition |
| 07/04/2007 | EP1802346A1 Sustained release pharmaceutical composition |
| 07/04/2007 | EP1802304A1 Cilostazol-containing pharmaceutical composition based on particles of less than 50 micrometers |
| 07/04/2007 | EP1802289A2 Compositions and their uses for lysosomal enzyme deficiencies |
| 07/04/2007 | EP1802288A2 Biodegradable polymeric microparticles |
| 07/04/2007 | EP1802287A2 Minicapsule formulations |
| 07/04/2007 | EP1802286A1 Sustained drug release composition demonstrating an ascending zero order release pattern, methods of manufacturing such a composition |
| 07/04/2007 | EP1802285A2 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| 07/04/2007 | EP1802284A1 Pool chemical tablet |
| 07/04/2007 | EP1802283A2 Bilayer tablet |
| 07/04/2007 | EP1802282A1 Biocompatible protein particles, particle devices and methods thereof |
| 07/04/2007 | EP1802281A1 Tablets comprising a poorly compressible active agent and tocopherol polyethyleneglycol succinate (tpgs) |
| 07/04/2007 | EP1802280A2 Clopidogrel compositions |
| 07/04/2007 | EP1802279A1 Caratenoid composition and method for preparation thereof |
| 07/04/2007 | EP1802278A2 Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds |
| 07/04/2007 | EP1802277A1 Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition |
| 07/04/2007 | EP1802276A1 Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| 07/04/2007 | EP1802275A2 Taste-masking pharmaceutical compositions |
| 07/04/2007 | EP1802259A1 Self-sealing antiseptic plaster |
| 07/04/2007 | EP1802250A1 Methods of treating wounds with gonyautoxins |
| 07/04/2007 | EP1802203A1 Animal feedstuff dyeing and animal drugs |
| 07/04/2007 | EP1624953A4 Sequestered reactive materials |